glp-1 mimetics Table 2 from Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Drug Class Review GLP-1 Receptor Agonists: Mascots &

GLP-1 medications are FDA-approved and clinically proven when prescribed and monitored by a physician

Who is eligible for GLP-1

The administration of pharmacologic quantities of GLP-1 analogs result in plasma activities that are 5- to 7-fold higher than physiologic levels

The most commonly reported side effect among those who took orforglipron included mild to moderate gastrointestinal issues, such as constipation, diarrhea, indigestion, nausea, and vomiting

The diagnosis of SGLT2 inhibitor-associated DKA can be challenging, often resembling conditions like infection, seizures, or alcoholic ketoacidosis [11]

Pennington and Dr